You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

somatostatin analogs

Showing 1 - 25 of 437
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in United States (Octreotide, LAR Lanreotide, Questionnaires)

Active, not recruiting
  • Neuroendocrine Tumors
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2022

Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

Recruiting
  • Neuroendocrine Tumor
  • +2 more
  • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
  • +3 more
  • Bordeaux, France
  • +3 more
Nov 18, 2021

Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

Recruiting
  • Liver Cirrhosis
  • +4 more
  • Somatostatin and its analogs
  • Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection
  • Shenyang, Liaoning, China
    Department of Gastroenterology, General Hospital of Shenyang Mil
Mar 17, 2022

Somatostatin Analogs, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Rochester (Pasireotide

Completed
Has Results
  • Somatostatin Analogs
  • +3 more
  • Pasireotide LAR
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic
Apr 30, 2020

Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Somatostatin analog
  • Brasschaat, Antwerp, Belgium
  • +19 more
Jan 31, 2023

Pancreatic Neuroendocrine Tumors in MEN1 Trial (Somatostatin-Analog)

Not yet recruiting
  • Pancreatic Neuroendocrine Tumors in MEN1
  • (no location specified)
Apr 5, 2019

Midgut Carcinoid Tumor, Biliary Stones Trial in Spain (Primary tumor surgery, Primary tumor surgery (bowel resection) combined

Recruiting
  • Midgut Carcinoid Tumor
  • Biliary Stones
  • Primary tumor surgery
  • Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy
  • Badalona, Barcelona, Spain
  • +5 more
Jul 6, 2022

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated

Unknown status
  • Gastric NET
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 20, 2019

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 13, 2023

Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

Recruiting
  • Neuroendocrine Tumor
  • +4 more
  • Cabozantinib 40 mg
  • Badalona, Barcelona, Spain
  • +14 more
Feb 15, 2022

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

Recruiting
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy
  • Rotterdam, South Holland, Netherlands
    Erasmus MC
May 19, 2023

Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

Recruiting
  • Metastatic Well Differentiated Neuroendocrine Neoplasm
  • Neuroendocrine Tumors
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Health Care
Jul 24, 2021

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy (PRRT) Trial in Ferrara (Lutetium-177 (177Lu)-DOTATOC, Yttrium-90

Recruiting
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy (PRRT)
  • Lutetium-177 (177Lu)-DOTATOC
  • +4 more
  • Ferrara, Italy
    University Hospital of Ferrara
Mar 5, 2021

Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)

Recruiting
  • Neuroendocrine Neoplasm
  • Biospecimen Collection
  • +4 more
  • Duarte, California
  • +3 more
Jan 12, 2023

(PRRT) for the Treatment of Neuroendocrine Tumors

Enrolling by invitation
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Oct 27, 2021

Congenital Hyperinsulinism, Insulinoma, Hyperinsulinism Trial (Pasireotide 0.6Mg Solution for Injection, Saline Solution)

Withdrawn
  • Congenital Hyperinsulinism
  • +2 more
  • Pasireotide 0.6Mg Solution for Injection
  • Saline Solution
  • (no location specified)
May 12, 2021

Neuroendocrine Tumors Trial in Milan (Lanreotide and Metformin)

Active, not recruiting
  • Neuroendocrine Tumors
  • Lanreotide and Metformin
  • Milan, Italy
    NationalCIMilan
Jun 4, 2021

Non-variceal Gastrointestinal Bleeding Trial in Cairo (PPI group, PPI plus octreotide)

Recruiting
  • Non-variceal Gastrointestinal Bleeding
  • PPI group
  • PPI plus octreotide
  • Cairo, Egypt
    NHTMRI
Sep 28, 2023

Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

Recruiting
  • Metastatic Digestive System Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Tumor
  • Phoenix, Arizona
  • +10 more
Aug 23, 2022

Healthy Trial in Copenhagen, Hvidovre (Proton Pump inhibitor, Placebo)

Recruiting
  • Healthy
  • Proton Pump inhibitor
  • Placebo
  • Copenhagen, Capital, Denmark
  • +1 more
Nov 1, 2023